Trump order on drug pricing appears to issue subtle threat to pharma

Taking stock of the drug industry, from the lab to the medicine chest

May 13, 2025 Check out STAT+

Sponsored By

By Ed Silverman Pharmalot Columnist, Senior Writer

Anna Moneymaker/Getty Images STAT+ | Trump order on drug pricing appears to issue subtle threat to pharma The order empowers the FDA to withdraw approvals if prices aren't lowered, a step experts say would be illegal. By Ed Silverman STAT+ | Trump wants Europe to pay up for drugs to help lower prices for Americans. It won't be easy The continent's health care system leaves the U.S. with limited leverage, and many countries are already wrestling with growing health expenditures. By Andrew Joseph STAT+ | UnitedHealth stock tumbles as CEO resigns, 2025 outlook pulled The CEO stepped down as UnitedHealth confronts surging medical costs in Medicare Advantage and a variety of other challenges. By Bob Herman and Andrew Joseph Fran van Delft for Galapagos Galapagos changes its mind on its big shakeup Today's biotech news spans new leadership at UnitedHealth, Elizabeth Holmes' partner's new startup, and RA Capital layoffs. By Elaine Chen

More around STAT

Check out more exclusive coverage with a STAT+ subscription Read premium in-depth biotech, pharma, policy, and life science coverage and analysis with all of our STAT+ articles.

---

Enjoying Pharmalot? Tell us about your experience Continue reading the latest health & science news with the STAT app Download on the App Store or get it on Google Play

STAT, 1 Exchange Place, Boston, MA ©2025, All Rights Reserved. I no longer wish to receive STAT emails

Update Newsletter Preferences     •    Contact Us     •    Advertise with Us     •    View in Browser